戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 nemia and severe cryoglobulinemia-associated membranoproliferative glomerulonephritis.
2 recurrent bacterial infections and to type 1 membranoproliferative glomerulonephritis.
3 tis, IgA nephropathy, Alport's syndrome, and membranoproliferative glomerulonephritis.
4 ed with diseases such as IgA nephropathy and membranoproliferative glomerulonephritis.
5                       Two patients developed membranoproliferative glomerulonephritis.
6 athological diagnoses on renal biopsies were membranoproliferative glomerulonephritis (23%) followed
7 as been associated with de novo or recurrent membranoproliferative glomerulonephritis and acute trans
8 d-stage renal disease in 12; one patient had membranoproliferative glomerulonephritis and another pat
9 een reported to be typically associated with membranoproliferative glomerulonephritis and less freque
10                                This included membranoproliferative glomerulonephritis and relapses in
11 nty-one patients with biopsy-proven, diffuse membranoproliferative glomerulonephritis and significant
12 al was seen with recurrent and de novo FSGS, membranoproliferative glomerulonephritis, and HUS/TTP.
13 hey developed splenomegaly, lymphadenopathy, membranoproliferative glomerulonephritis, and lymphocyti
14 nephritides (e.g. Alport's Syndrome, type II membranoproliferative glomerulonephritis, and membranous
15 vere kidney disorders including mesangial or membranoproliferative glomerulonephritis, and/or Henoch
16 gy, whereas overexpression of TSLP induced a membranoproliferative glomerulonephritis, as previously
17 ciated with hemolytic uremic syndrome (HUS), membranoproliferative glomerulonephritis (dense deposit
18 By 6 months of age, ABCA1-/- animals develop membranoproliferative glomerulonephritis due to depositi
19  (FSGS), 57; immunoglobulin A nephritis, 22; membranoproliferative glomerulonephritis (GN), 18; and m
20 enal (membranous glomerulonephritis [GN] and membranoproliferative glomerulonephritis); hematologic (
21 ulting from other glomerular diseases (FSGS, membranoproliferative glomerulonephritis, IgA nephropath
22 malities in factor H have been implicated in membranoproliferative glomerulonephritis in both humans
23 ch was before the development of spontaneous membranoproliferative glomerulonephritis in some Cfh(-/-
24  in a mouse model of cryoglobulin-associated membranoproliferative glomerulonephritis induced by over
25 riably demonstrating severe neonatal anemia, membranoproliferative glomerulonephritis, liver fibrosis
26                We also evaluated the risk of membranoproliferative glomerulonephritis (MPGN) and cryo
27                                              Membranoproliferative glomerulonephritis (MPGN) is seen
28                                              Membranoproliferative glomerulonephritis (MPGN) occurs i
29                                              Membranoproliferative glomerulonephritis (MPGN) recently
30 opathies, such as IgA nephropathy (IgAN) and membranoproliferative glomerulonephritis (MPGN) remains
31                                              Membranoproliferative glomerulonephritis (MPGN) type II
32 , a model of cryoglobulinemia and associated membranoproliferative glomerulonephritis (MPGN), in whic
33 TSLPtg) mice, which develop cryoglobulinemic membranoproliferative glomerulonephritis (MPGN).
34 y progressive glomerulonephritis (RPGN), and membranoproliferative glomerulonephritis (MPGN).
35 tic nephropathy, membranous lupus nephritis, membranoproliferative glomerulonephritis, postinfectious
36                                              Membranoproliferative glomerulonephritis recurred in eig
37 3 glomerulopathies/immune complex-associated membranoproliferative glomerulonephritis, serum-induced
38 ients had immune-complex glomerulonephritis: membranoproliferative glomerulonephritis type 1 (n = 12)
39   The predominant renal biopsy findings were membranoproliferative glomerulonephritis type 1 or type
40 ceased donor transplants were not present in membranoproliferative glomerulonephritis type I (adjuste
41                                              Membranoproliferative glomerulonephritis type I [24 of 2
42 reviously published studies of patients with membranoproliferative glomerulonephritis type I are smal
43 allograft for end-stage renal disease due to membranoproliferative glomerulonephritis type I is prese
44                                              Membranoproliferative glomerulonephritis type II (MPGN I
45                                              Membranoproliferative glomerulonephritis type II (MPGN I
46 ypical hemolytic uremic syndrome (aHUS), and membranoproliferative glomerulonephritis type II (MPGN2)
47    Dense deposit disease (DDD; also known as membranoproliferative glomerulonephritis type II) is a p
48  nephropathy to 2.09 (95% CI, 1.56-2.78) for membranoproliferative glomerulonephritis type II.
49 innate immunity, and CFH deficiency leads to membranoproliferative glomerulonephritis type II.
50 plant FSGS was 2.25 (1.6-3.1), P<0.0001, for membranoproliferative glomerulonephritis was 2.37 (1.3-4
51     Renal involvement usually manifests as a membranoproliferative glomerulonephritis with marked mon
52 on with hepatitis C virus (HCV) infection is membranoproliferative glomerulonephritis, with or withou

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。